Showing results (181-190 of 476) with videos related to
Sort By:
Pageof 48
The Journal of General Physiology|February 16, 2011
N-terminal transmembrane domain of SUR1 controls gating of Kir6.2 by modulating channel sensitivity to PIP2Emily B Pratt, Paul Tewson, Cathrin E Bruederle, et al.Cancer|October 15, 1981
Malignant germ cell tumors in 57 children and adolescentsG M Brodeur, C B Howarth, C B Pratt, et al.Chest|April 20, 1999
Clickhaler (a novel dry powder inhaler) provides similar bronchodilation to pressurized metered-dose inhaler, even at low flow ratesM T Newhouse, N P Nantel, C B Chambers, et al.Theriogenology|October 1, 1985
Clenbuterol (planipart(trade mark)) for the postponement of parturition in cattleM R Putnam, L E Rice, R P Wettemann, et al.The Journal of Biological Chemistry|August 22, 1997
Folding of the glucocorticoid receptor by the heat shock protein (hsp) 90-based chaperone machinery. The role of p23 is to stabilize receptor.hsp90 heterocomplexes formed by hsp90.p60.hsp70K D Dittmar, D R Demady, L F Stancato, et al.Journal of Vascular Surgery Cases|November 15, 2019
The supraclavius muscle is a novel muscular anomaly observed in two cases of thoracic outlet syndromePayam Salehi, Wande B Pratt, Michael F Joseph, et al.The Journal of Biological Chemistry|April 15, 2000
Stepwise assembly of a glucocorticoid receptor.hsp90 heterocomplex resolves two sequential ATP-dependent events involving first hsp70 and then hsp90 in opening of the steroid binding pocketY Morishima, P J Murphy, D P Li, et al.The Journal of Biological Chemistry|March 9, 2004
Hsp90-binding immunophilins link p53 to dynein during p53 transport to the nucleusMario D Galigniana, Jennifer M Harrell, Heather M O'Hagen, et al.Journal of Pharmacokinetics and Biopharmaceutics|December 1, 1993
Saturable elimination and saturable protein binding account for flavone acetic acid pharmacokineticsM V Relling, R R Evans, S Groom, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Phase I clinical trial of recombinant human tumor necrosis factor in children with refractory solid tumors: a Pediatric Oncology Group studyW L Furman, D Strother, K McClain, et al.Pageof 48